While children under five, particularly those under two, are the most vulnerable, pneumococcal diseases also affect adults. The most common symptoms include cough, chills and fever.

How do the shots help Vaccination can protect against some of these infections and can prevent complications in children. It helps address pneumococcal bacterial infections, including pneumonia ...

Background: Pneumonia is the leading cause of morbidity and mortality among children <5 years of age globally. Pneumococcal conjugate vaccines (PCVs) are known to provide protection against ...

The European Medicines Agency (EMA) has recommended granting marketing authorization for the pneumococcal vaccine Capvaxive ...

Vaccines against certain kinds of pneumonia exist for adults, but many high-risk patients do not routinely receive them. A relatively new pneumococcal vaccine for children called Prevnar ...

The vaccines achieved a 79% reduction in pneumococcal pneumonia caused by the capsular ... capsular polysaccharides in children and young adults aged 2 to 25 years with sickle cell disease ...

A phase 2 study in children will also start ... There are around 100 different pneumococcal serotypes, causing non-invasive disease like pneumonia, confined to the lungs, and invasive disease ...

You have a good eye. This past fall, the Centers for Disease Control and Prevention changed the recommended age for getting the vaccine for pneumococcal pneumonia from those 65 and older to those 50 ...

Merck (NYSE: MRK), known as MSD outside of the United States and Canada, announced today that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA ...

Pneumococcal lobar pneumonia was chosen for this study because of the relatively sharp clinical end-point obtainable. A consecutive series of patients was treated with aqueous penicillin G given ...